Targeting 4-1BB (CD137) to enhance CD8 T cell responses with poxviruses and viral antigens

Attenuated vaccinia virus (VACV) vectors are considered prime vaccine candidates for use in immunotherapy of infectious disease. In spite of this, recent data show that the level of attenuation may hamper the efficient generation of protective CD8 T cells. This suggests that additional adjuvant-like...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Yuan, Tahiliani, Vikas, Salek-Ardakani, Shahram, Croft, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2012
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3492829/
https://www.ncbi.nlm.nih.gov/pubmed/23162550
http://dx.doi.org/10.3389/fimmu.2012.00332

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3492829/
https://www.ncbi.nlm.nih.gov/pubmed/23162550
http://dx.doi.org/10.3389/fimmu.2012.00332

Ejemplares similares